DeepValuesResearch
CompaniesInsightsMarketGurusPrinciplesBuffett ArchivePersonal FinanceBusiness NotesLatestBullish stocksNeutral stocksBearish stocksSectorsMost covered For agents & developers

AZNHealthcare · Drug Manufacturers - General

AstraZeneca PLC

DeepValues Research covers AstraZeneca (AZN) with 1 research report since Aug 8, 2026. The latest Deep Value Intelligence report (Aug 8, 2026) ends with a Bullish stance (3.33/5), with the stock at $161 against a headline intrinsic value of $198. Sector: Healthcare · Drug Manufacturers - General.

Latest stanceBullish3.33
Reports1since Aug 8, 2026
Latest reportEN

Research timeline

  1. Deep Value Intelligence

    AstraZeneca PLC (AZN) Deep Value Intelligence Report

    Bullish (3.33/5) on AstraZeneca (AZN), Aug 8, 2026. Price $161 vs intrinsic value $198, 18.5% margin of safety. ADVOCATE (Staged Accumulation) The…

    Bullish3.33EN32 min

Compare with other Healthcare companies

All Healthcare stocks
CompanyIndustryLatest stancePrice · valueDateReports
AZNAstraZeneca Drug Manufacturers - General Bullish3.33 $161 · $198 1
JNJJohnson & Johnson Drug Manufacturers - General Neutral3.08 $264 · $184 3
ABBVAbbVie Drug Manufacturers - General Bullish2.35 $257 · $151 11
LLYEli Lilly and Drug Manufacturers - General Neutral3.28 $920 2
GRDN Medical Care Facilities Bearish3.16 $40 · $14 1
ALLOAllogene Therapeutics Biotechnology Bearish3.10 $1 1
MRNA Biotechnology Neutral3.01 $199 · $448 1
CRSPCRISPR Therapeutics Biotechnology Neutral2.30 $56 1
INSMInsmed Biotechnology Bearish2.52 $118 1

Charts from the latest report

Open report
Fundamentals Key MetricsFundamentals Key MetricsFundamentals Key MetricsYear Financial Metrics (Profitability)Year Financial Metrics (Health)Revenue BreakdownLatest Earnings SnapshotCurrent vs. 10-Year Historical Average ComparisonThree-Scenario Buffett-Style Owner Earnings DCFIntrinsic Value Cross-Check from Research PackMarket Metrics Interpretation